🇺🇸 FDA

Company profile · Sponsor

GenSight

GenSight Biologics S.A.

E3BA9EF · EMA pharma EU
Pipeline
2
Drugs
0
Patents
0

Quick answer

GenSight (E3BA9EF) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E3BA9EF
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (2)

Search pipeline →

  1. GS030-DP, GS030-DP, GS030-DP

    GenSight

    Retinitis Pigmentosa

    phase 2 small molecule active

    1 trial

  2. Lumevoq

    GenSight

    Leber Hereditary Optic Neuropathy due to mutations in the mitochondrial NADH Dehydrogenase 4 gene

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is GenSight?

GenSight (E3BA9EF) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does GenSight sponsor?

We track 2 ClinicalTrials.gov-linked programs for GenSight, including GS030-DP, GS030-DP, GS030-DP and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does GenSight company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.